Intercept Pharmaceuticals

+$0.06 (+0.28%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ICPT and other stocks, options, and ETFs commission-free!

About ICPT

Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development and commercialization of novel therapeutics in treating chronic liver diseases.

CEO
Jerome B. Durso
Employees
498
Headquarters
New York, New York
Founded
2002

ICPT Key Statistics

Market Cap
714.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
860.24K
High Today
$21.66
Low Today
$20.91
Open Price
$21.66
Volume
545.92K
52 Week High
$83.57
52 Week Low
$13.88

ICPT Earnings

-$2.99
-$1.99
-$1.00
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure